Funded Tech Companies
Nuclidium
Wondering who backed Nuclidium? Wellington Partners, Angelini Ventures and DeepTech & Climate Fonds joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Nuclidium
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Im Erasmushaus, Bäumleingasse 18
Basel, 4051
Switzerland
Basel, 4051
Switzerland
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
NUCLIDIUM's vision is to address the unmet need in cancer medicine by providing personalised treatment options for cancer patients at every stage of their disease to improve long-term survival. Our therapeutic approach combines accurate diagnosis and staging of cancers at an early stage with a highly personalized treatment dose enabling less aggressive treatment and a significantly better quality of life for the patient.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/10/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leila Jaafar-Thiel
Company Investors
- Wellington Partners
- Angelini Ventures
- DeepTech & Climate Fonds
- HighLight Capital
- Neva SGR
- Eurazeo
- Kurma Partners
- Bayern Kapital
- Vives Louvain Technology Fund
- NRW.BANK
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs